Cooper Companies Inc
COO
View Detailed Chart
67.395USD
+2.815+4.36%
Close 08/29, 16:00（ET）Quotes delayed by 15 min
13.40BMarket Cap
32.35P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+4.36%
5 Days
-10.40%
1 Month
-8.55%
6 Months
-25.43%
Year to Date
-26.69%
1 Year
-36.26%
View Detailed Chart
TradingKey Stock Score
Currency: USD Updated：2025-08-29Key Insights
The company's fundamentals are relatively healthy.Its valuation is considered undervalued,and institutional recognition is very high.Over the past 30 days, multiple analysts have rated the company as a Buy.Despite an average stock market performance, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analysts' Target
Based on
19
analysts
Buy
Current Rating
86.027
Target Price
+33.21%
Upside Space
Disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
The Cooper Companies, Inc. is a global medical device company. The Company operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. It also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 17.74% year-on-year.
Undervalued
The company’s latest PE is 32.45, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 201.42M shares, decreasing 1.64% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 24.16M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.52.
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
The Cooper Companies, Inc. is a global medical device company. The Company operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. It also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.
Ticker SymbolCOO
CompanyCooper Companies Inc
CEOMr. Albert G. White, III
Websitehttps://www.coopercos.com/
Related Instruments
+0.98%
+0.45%
+0.92%
+0.59%
+0.90%
+0.01%
+0.47%
+0.35%
+0.12%
+0.68%
+0.99%
+0.61%
+0.59%
+1.19%
+0.59%
+0.35%
+0.59%
+0.80%
+4.58%
+0.23%
